Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03103789Enrolling By Invitation

Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device

Role: collaborator

NCT02995395Completed

Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)

Role: collaborator

NCT00857597Phase 3Terminated

Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

Role: collaborator

All 3 trials loaded